Graphene based nanostructure interaction with human liver cancer cells

  • Dr Khadijeh Yousefi
  • Mehdi Golkar fard
Keywords: Carbon-based nanomaterials, liver cancer



  Carbon-based nanomaterials are now in the spotlight of biomedical researches. According to the World Health Organization, liver cancer is the fourth driving cause of cancer associated with passing around the world. It requests compelling treatment and demonstrative techniques to ruin its recurrence, complexities, forceful metastasis and late determination. With later advance in nanotechnology, Graphene based nanostructure (GBNs) symptomatic and helpful modalities have entered into clinical trials. With further developments in Graphene based nanostructure intervened liver cancer conclusion and treatment, the approach holds promise for made strides clinical liver cancer administration. In this mini-review emphasis is given to special applications such as Structure and Properties, Synthesis, differentiation, Biomedical Applications, and Limitations of nanoparticles through liver cancer cells. Finally, the future perspectives of GBNs in the liver cancer cells field have been discussed.


Download data is not yet available.


[1] M. Kutwin et al., "Nanocomplexes of Graphene Oxide and Platinum Nanoparticles against Colorectal Cancer Colo205, HT-29, HTC-116, SW480, Liver Cancer HepG2, Human Breast Cancer MCF-7, and Adenocarcinoma LNCaP and Human Cervical Hela B Cell Lines," Materials (Basel), vol. 12, no. 6, Mar 19 2019.
[2] S. M. Mousavi et al., "Multifunctional Gold Nanorod for Therapeutic Applications and Pharmaceutical Delivery Considering Cellular Metabolic Responses, Oxidative Stress and Cellular Longevity," Nanomaterials, vol. 11, no. 7, p. 1868, 2021.
[3] T. A. Salaheldin, S. A. Loutfy, M. A. Ramadan, T. Youssef, and S. A. Mousa, "IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model," Int J Nanomedicine, vol. 14, pp. 4397-4412, 2019.
[4] E. Kim and P. Viatour, "Hepatocellular carcinoma: old friends and new tricks," Exp Mol Med, vol. 52, no. 12, pp. 1898-1907, Dec 2020.
[5] M. M. H. Chowdhury, C. J. J. Salazar, and M. Nurunnabi, "Recent advances in bionanomaterials for liver cancer diagnosis and treatment," Biomater Sci, vol. 9, no. 14, pp. 4821-4842, Jul 13 2021.
[6] S. M. Mousavi et al., "Recent Advancements in Polythiophene-Based Materials and their Biomedical, Geno Sensor and DNA Detection," International Journal of Molecular Sciences, vol. 22, no. 13, p. 6850, 2021.
[7] K. Buskaran, M. Z. Hussein, M. A. M. Moklas, M. J. Masarudin, and S. Fakurazi, "Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application," Int J Mol Sci, vol. 22, no. 11, May 28 2021.
[8] S. A. Loutfy, T. A. Salaheldin, M. A. Ramadan, Y. Farroh Kh, Z. F. Abdallah, and T. Youssef, "Synthesis, Characterization and Cytotoxic Evaluation of Graphene Oxide Nanosheets: In Vitro Liver Cancer Model," Asian Pac J Cancer Prev, vol. 18, no. 4, pp. 955-961, Apr 1 2017.
[9] T. P. Dasari Shareena, D. McShan, A. K. Dasmahapatra, and P. B. Tchounwou, "A Review on Graphene-Based Nanomaterials in Biomedical Applications and Risks in Environment and Health," Nanomicro Lett, vol. 10, no. 3, p. 53, Jul 2018.
[10] S. M. Mousavi et al., "Asymmetric membranes: a potential scaffold for wound healing applications," Symmetry, vol. 12, no. 7, p. 1100, 2020.
[11] S. M. Mousavi et al., "Development of graphene based nanocomposites towards medical and biological applications," Artificial cells, nanomedicine, and biotechnology, vol. 48, no. 1, pp. 1189-1205, 2020.
[12] G. Reina, J. M. Gonzalez-Dominguez, A. Criado, E. Vazquez, A. Bianco, and M. Prato, "Promises, facts and challenges for graphene in biomedical applications," Chem Soc Rev, vol. 46, no. 15, pp. 4400-4416, Jul 31 2017.
[13] S. M. Mousavi et al., "Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy," RSC Advances, vol. 10, no. 22, pp. 12851-12863, 2020.
[14] A. Gholami et al., "3D nanostructures for tissue engineering, cancer therapy, and gene delivery," Journal of Nanomaterials, vol. 2020, 2020.
[15] A. Jana, E. Scheer, and S. Polarz, "Synthesis of graphene-transition metal oxide hybrid nanoparticles and their application in various fields," Beilstein J Nanotechnol, vol. 8, pp. 688-714, 2017.
[16] D. R. Dreyer, R. S. Ruoff, and C. W. Bielawski, "From conception to realization: an historial account of graphene and some perspectives for its future," Angew Chem Int Ed Engl, vol. 49, no. 49, pp. 9336-44, Dec 3 2010.
[17] K. Muthoosamy and S. Manickam, "State of the art and recent advances in the ultrasound-assisted synthesis, exfoliation and functionalization of graphene derivatives," Ultrason Sonochem, vol. 39, pp. 478-493, Nov 2017.
[18] B. R. Stoner, B. Brown, and J. T. Glass, "Selected Topics on the Synthesis, Properties and Applications of Multiwalled Carbon Nanotubes," Diam Relat Mater, vol. 42, pp. 49-57, Feb 1 2014.
[19] X. HUANG, F. BOEY, and H. ZHANG, "A BRIEF REVIEW ON GRAPHENE-NANOPARTICLE COMPOSITES," COSMOS, vol. 06, no. 02, pp. 159-166, 2010.
[20] M. Agharkar, S. Kochrekar, S. Hidouri, and M. A. Azeez, "Trends in green reduction of graphene oxides, issues and challenges: a review," Materials Research Bulletin, vol. 59, pp. 323-328, 2014.
[21] S. Thakur and N. Karak, "Alternative methods and nature-based reagents for the reduction of graphene oxide: A review," Carbon, vol. 94, pp. 224-242, 2015.
[22] H. Zhang, G. Gruner, and Y. Zhao, "Recent advancements of graphene in biomedicine," J Mater Chem B, vol. 1, no. 20, pp. 2542-2567, May 28 2013.
[23] Z. Singh, "Applications and toxicity of graphene family nanomaterials and their composites," Nanotechnol Sci Appl, vol. 9, pp. 15-28, 2016.
[24] K. S. Novoselov et al., "Electric field effect in atomically thin carbon films," Science, vol. 306, no. 5696, pp. 666-9, Oct 22 2004.
[25] G. Shim, M. G. Kim, J. Y. Park, and Y. K. Oh, "Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs," Adv Drug Deliv Rev, vol. 105, no. Pt B, pp. 205-227, Oct 1 2016.
[26] M. Ahamed, M. J. Akhtar, and M. A. M. Khan, "Investigation of Cytotoxicity, Apoptosis, and Oxidative Stress Response of Fe3O4-RGO Nanocomposites in Human Liver HepG2 cells," Materials (Basel), vol. 13, no. 3, Feb 2 2020.
[27] D. G. Goodwin, Jr., A. S. Adeleye, L. Sung, K. T. Ho, R. M. Burgess, and E. J. Petersen, "Detection and Quantification of Graphene-Family Nanomaterials in the Environment," Environ Sci Technol, vol. 52, no. 8, pp. 4491-4513, Apr 17 2018.
[28] F. Barahuie et al., "Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid," Mater Sci Eng C Mater Biol Appl, vol. 74, pp. 177-185, May 1 2017.
[29] S. Bajpai et al., "Recent Advances in Nanoparticle-Based Cancer Treatment: A Review," ACS Applied Nano Materials, 2021.
[30] M. Nurunnabi et al., "Bioapplication of graphene oxide derivatives: drug/gene delivery, imaging, polymeric modification, toxicology, therapeutics and challenges," RSC advances, vol. 5, no. 52, pp. 42141-42161, 2015.
[31] M. Georgieva et al., "Amination of Graphene Oxide Leads to Increased Cytotoxicity in Hepatocellular Carcinoma Cells," Int J Mol Sci, vol. 21, no. 7, Mar 31 2020.
[32] U. Ruman, S. Fakurazi, M. J. Masarudin, and M. Z. Hussein, "Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities," Int J Nanomedicine, vol. 15, pp. 1437-1456, 2020.
[33] B. Baig, S. A. Halim, A. Farrukh, Y. Greish, and A. Amin, "Current status of nanomaterial-based treatment for hepatocellular carcinoma," Biomed Pharmacother, vol. 116, p. 108852, Aug 2019.
[34] Y. Cao et al., "Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721," Drug Deliv, vol. 27, no. 1, pp. 258-268, Dec 2020.
[35] X. Chi et al., "Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma," Nanotechnology, vol. 30, no. 17, p. 175101, Apr 26 2019.
[36] Y. Han et al., "Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma," Nanoscale, vol. 10, no. 14, pp. 6511-6523, Apr 5 2018.
[37] T. Ai et al., "Near infrared-emitting persistent luminescent nanoparticles for Hepatocellular Carcinoma imaging and luminescence-guided surgery," Biomaterials, vol. 167, pp. 216-225, Jun 2018.
[38] F. F. Moghadam, "Using Nanoparticles in Medicine for Liver Cancer Imaging," Oman Med J, vol. 32, no. 4, pp. 269-274, Jul 2017.
[39] Y. Cao and H.-W. Zhang, "Recent Advances In Nano Material-Based Application Of Liver Neoplasms," Smart Materials in Medicine, 2021.
[40] K. P. Loh, Q. Bao, G. Eda, and M. Chhowalla, "Graphene oxide as a chemically tunable platform for optical applications," Nat Chem, vol. 2, no. 12, pp. 1015-24, Dec 2010.
[41] T. Lammel, P. Boisseaux, M. L. Fernandez-Cruz, and J. M. Navas, "Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2," Part Fibre Toxicol, vol. 10, p. 27, Jul 12 2013.
[42] S. Jaworski et al., "In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells," Int J Nanomedicine, vol. 8, pp. 413-20, 2013.
[43] Y. Chang et al., "In vitro toxicity evaluation of graphene oxide on A549 cells," Toxicol Lett, vol. 200, no. 3, pp. 201-10, Feb 5 2011.
[44] S. Tran, P. J. DeGiovanni, B. Piel, and P. Rai, "Cancer nanomedicine: a review of recent success in drug delivery," Clin Transl Med, vol. 6, no. 1, p. 44, Dec 11 2017.
How to Cite
Yousefi DK, Golkar fard M. Graphene based nanostructure interaction with human liver cancer cells. AANBT [Internet]. 19Sep.2021 [cited 4Oct.2022];2(4):60-1. Available from: